Demand pull is outrunning the plan for one still-small offering, and the company is visibly re-pointing itself at it
The model's full reasoning — Q1 2022 call → NOWe need to determine if management describes an identifiable offering with both: (1) customer response running ahead of what company prepared for, and (2) company responding now by putting more behind it. The offering must be small relative to total business. Scan transcript for such descriptions. Management discusses CTV, DV+, audience/identity, etc. They mention "Binge watcher product" from SpringServe? Actually they mention "Spring serves newly announced Binge watcher product, a tool set to rapidly review creatives and improve the user experience." That's a product but no mention of demand ahead of plan. They discuss "GroupM preferred partnership" but that's a partnership, not an offering with uptake ahead of plan. They discuss "OpenPass" from Trade Desk but that's external. They discuss "seller-defined audiences" and acquisitions like Nth Party and Carbon. But no mention of current uptake ahead of plan. They discuss "political spend" but that's future. They discuss "CTV" as a whole, but that's main business? CTV is 40% of revenue, so not small. They discuss "DV+" but that's established. They discuss "SpringServe" integration but no demand ahead. They discuss "Binge watcher" but no uptake. They discuss "prebid" and "Demand Manager" but no. They discuss "managed service business on CTV side" with return of verticals, but that's not ahead of plan. They discuss "GroupM SPO deal" but that's a deal, not an offering. They discuss "Disney+ ad-supported" but that's external. No mention of an offering where customer response is running ahead of what they prepared for. They mention "we have a track record of building custom software" but no. They mention "we are constantly innovating" but no. They mention "we see upside to those growth rates" but that's projection. They mention "we have some really significant tailwinds" but that's future. They mention "we are well down the path" for DV+ improvements but no demand ahead. They mention "we are building for that future" for seller-defined audiences but no current uptake. Thus, no such offering described. Answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| HCKT | The Hackett Group, Inc. | Q1 2024 | 2024-05-08 | C |
| ROCK | Gibraltar Industries, Inc. | Q1 2024 | 2024-05-01 | B+ |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| ESRT | Empire State Realty Trust, Inc. | Q2 2021 | 2021-07-29 | C+ |
HCKT · Q1 2024 → YESThe question is about whether management describes one identifiable offering that's still small, where customer response is ahead of what they prepared for, AND they're responding now by putting more ...YES The transcript describes AI Explorer (the GenAI assessment platform) as a small, early-stage offering (nominal Q1 revenue impact, part of broader GenAI pivot). Management states customer response is exceeding preparation: "over 175 demo meetings with many more scheduled... resulted in a number of new enterprise...
SYY · Q1 2023 → YESThe question is about whether management describes one identifiable offering or initiative that's still a smaller part of the business, where customer response is running ahead of what they prepared f...YES The transcript shows that Sysco Your Way is presented as a smaller, still-developing offering (described as part of the Recipe For Growth pillars, with its scale expected to grow each quarter and currently limited to specific neighborhoods and recent international rollouts like Toronto and Dublin).
PRPH · Q1 2023 → YESThe question asks if management describes one identifiable offering that's still a smaller part of the business, where customer response is running ahead of what they prepared for, AND they're respond...YES The lozenge manufacturing facility is the clearest match. It is explicitly described as “the least interesting business we’re developing” and still a smaller slice of overall results (COVID testing was the dominant revenue driver for the prior two years).